Clinical Trial Update: Sirtuin-NAD Activator in Alzheimer's Disease [Phase 1, Phase 2]

View source ↗

Summary

This clinical-trial update reports an ongoing Phase 1/2 study of a Sirtuin-NAD activator for Alzheimer's disease and dementia, currently listed as active but no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Dementia

Drugs mentioned

• Sirtuin-NAD Activator

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Alzheimer's Disease (Incl Subtypes), Dementia | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING